Logo image
Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis
Journal article   Peer reviewed

Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis

Nitin A Pagedar, Catherine Chioreso, Jennifer A Schlichting, Charles F Lynch and Mary E Charlton
Cancer causes & control, Vol.28(10), pp.1085-1093
10/2017
DOI: 10.1007/s10552-017-0938-3
PMCID: PMC5771802
PMID: 28815336
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5771802View
Open Access

Abstract

Treatment for oropharyngeal cancer (OPC) has changed over the past two decades under multiple influences. We provide a population-based description of the application of radiotherapy, surgery, and chemotherapy to OPC in 1997, 2004, and 2009. The National Cancer Institute's Patterns of Care study for OPC included multiple variables not available in the public-use dataset. We identified factors correlating with selection of primary surgery versus radiotherapy with or without chemotherapy (RTC) and analyzed predictors of all-cause mortality. We estimated the frequency of human papillomavirus (HPV) testing. RTC was more common in 2009 than in 1997, and was more commonly applied to Stage IV cases. However, RTC was not an independent risk factor for mortality compared with surgery. HPV status was known in 14% of patients in 2009. RTC is the most common treatment for OPC, but it may not provide the best outcomes. HPV testing was uncommon in 2009.
Oropharyngeal Neoplasms - therapy SEER Program Humans Middle Aged Papillomavirus Infections - epidemiology Risk Factors Male Oropharyngeal Neoplasms - virology Oropharyngeal Neoplasms - epidemiology Delivery of Health Care Adult Female Papillomaviridae Papillomavirus Infections - virology Aged

Details

Metrics

Logo image